SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-16-004689
Filing Date
2016-04-18
Accepted
2016-04-18 16:05:37
Documents
5
Period of Report
2016-06-03
Effectiveness Date
2016-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A adms-20160603xdef14a.htm DEF 14A 828042
2 GRAPHIC adms20160603xdef14a001.jpg GRAPHIC 3700
3 GRAPHIC adms20160603xdef14a002.jpg GRAPHIC 19006
4 GRAPHIC adms20160603xdef14a003.jpg GRAPHIC 61943
5 GRAPHIC adms20160603xdef14a004.gif GRAPHIC 38284
  Complete submission text file 0001558370-16-004689.txt   998797
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36399 | Film No.: 161576979
SIC: 2834 Pharmaceutical Preparations